SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model
Related Experiment Video
Updated: Dec 8, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
Jihong Jiang1, Baoji Hu2, Chun-Shiang Chung3
1Department of Anesthesiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, P.R. China.
Background:
Hypovolemic shock and septic challenge are two major causes of acute kidney injury (AKI) in the clinic setting. Src homology 2 domain-containing phosphatase 2 (SHP2) is one of the major protein phosphatase tyrosine phosphatase (PTPs), which play a significant role in maintaining immunological homeostasis by regulating many facets of immune cell signaling. In this study, we explored whether SHP2 signaling contributed to development of AKI sequential hemorrhage (Hem) and cecal ligation and puncture (CLP) and whether inactivation of SHP2 through administration of its selective inhibitor, phenylhydrazonopyrazolone sulfonate 1 (PHPS1), attenuated this injury.
Methods:
Male C57BL/6 mice were subjected to Hem (a "priming" insult) followed by CLP or sham-Hem plus sham-CLP (S/S) as controls. Samples of blood and kidney were harvested at 24 h post CLP. The expression of neutrophil gelatinase-associated lipocalin (NGAL), high mobility group box 1 (HMGB1), caspase3 as well as SHP2:phospho-SHP2, extracellular-regulated kinase (Erk1/2): phospho-Erk1/2, and signal transducer and activator of transcription 3 (STAT3):phospho-STAT3 protein in kidney tissues were detected by Western blotting. The levels of creatinine (Cre) and blood urea nitrogen (BUN) in serum were measured according to the manufacturer's instructions. Blood inflammatory cytokine/chemokine levels were detected by ELISA.
Results:
We found that indices of kidney injury, including levels of BUN, Cre and NGAL as well as histopathologic changes, were significantly increased after Hem/CLP in comparison with that in the S/S group. Furthermore, Hem/CLP resulted in elevated serum levels of inflammatory cytokines/chemokines, and induced increased levels of HMGB1, SHP2:phospho-SHP2, Erk1/2:phospho-Erk1/2, and STAT3:phospho-STAT3 protein expression in the kidney. Treatment with PHPS1 markedly attenuated these Hem/CLP-induced changes.
Conclusions:
In conclusion, our data indicate that SHP2 inhibition attenuates AKI induced by our double-hit/sequential insult model of Hem/CLP and that this protective action may be attributable to its ability to mitigate activation of the Erk1/2 and STAT3 signaling pathway. We believe this is a potentially important finding with clinical implications warranting further investigation.
Insights
Inhibiting SHP2 (Src homology 2 domain-containing phosphatase 2) with PHPS1 reduces acute kidney injury (AKI) caused by sequential hemorrhage and sepsis. This SHP2 inhibition protects kidneys by mitigating Erk1/2 and STAT3 signaling pathways.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Acute kidney injury (AKI) is a significant clinical problem often caused by hypovolemic shock and sepsis.
- Src homology 2 domain-containing phosphatase 2 (SHP2) plays a crucial role in immune cell signaling and maintaining immunological homeostasis.
Purpose of the Study:
- To investigate the role of SHP2 signaling in AKI induced by a sequential hemorrhage (Hem) and cecal ligation and puncture (CLP) model.
- To determine if inhibiting SHP2 with phenylhydrazonopyrazolone sulfonate 1 (PHPS1) could attenuate this AKI.
Main Methods:
- Male C57BL/6 mice underwent Hem followed by CLP, or sham procedures.
- Kidney and blood samples were analyzed for markers of kidney injury (BUN, creatinine, NGAL), inflammation (cytokines/chemokines), and key signaling proteins (SHP2, Erk1/2, STAT3).
- SHP2 activity was inhibited using its selective inhibitor, PHPS1.
Main Results:
- The Hem/CLP model significantly increased markers of kidney injury and inflammation compared to controls.
- Hem/CLP elevated levels of HMGB1 and activated SHP2, Erk1/2, and STAT3 signaling in kidney tissues.
- PHPS1 treatment markedly reduced Hem/CLP-induced kidney injury and inflammatory responses.
Conclusions:
- SHP2 inhibition effectively attenuates AKI in a preclinical model of combined hemorrhage and sepsis.
- The protective effect of SHP2 inhibition is likely mediated by the suppression of Erk1/2 and STAT3 signaling pathways.
- These findings suggest SHP2 inhibition as a potential therapeutic strategy for AKI with significant clinical implications.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
The JAK-STAT Signaling Pathway

